a year ago
AXGN
AnalystsConstantine DavidesConstantine Davides's Stock Forecasts
AnalystsConstantine Davides
Analyst Ranking
Bottom 1%
#5254 out of 5278 analysts
Average Return
-21.51%
Win Rate
29%36 out of 124
Risk vs Reward
Poor
Good
Constantine Davides's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Optimizerx CorpOPRX | +280.79% | $4.06 | $15.46 | 2024-11-14 - 2025-11-13 | Buy |
Biovie IncBIVI | +217.17% | $332.00 | $1,053.00 | 2022-03-17 - 2023-03-16 | Strong Buy |
Optimizerx CorpOPRX | +91.29% | $5.51 | $10.54 | 2025-02-06 - 2026-02-05 | Buy |
Nanoviricides IncNNVC | +83.91% | $1.31 | $2.40 | 2023-06-01 - 2024-05-31 | Strong Buy |
Amn Healthcare Services IncAMN | +78.37% | $16.04 | $28.61 | 2025-12-19 - 2026-05-15 | Buy |
Constantine Davides Analyst Color
Get additional color on Constantine Davides's coverage of popular stocks
Constantine Davides's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Progyny IncPGNY | 4 | Buy | $31.00 | +33.33% | Maintains | 7 days ago |
U S Physical Therapy IncUSPH | 3 | Buy | $98.00 | +56.03% | Maintains | 10 days ago |
Omada Health IncOMDA | 2 | Buy | $21.00 | +26.81% | Maintains | 10 days ago |
Addus Homecare CorpADUS | 5 | Buy | $142.00 | +56.08% | Maintains | 12 days ago |
Amn Healthcare Services IncAMN | 14 | Buy | $24.00 | -16.11% | Maintains | 3 months ago |
Option Care Health IncOPCH | 8 | Buy | $38.00 | +94.67% | Reiterates | 4 months ago |
Evolent Health IncEVH | 11 | Buy | $10.00 | +152.53% | Maintains | 4 months ago |
Healthequity IncHQY | 6 | Buy | $122.00 | +48.47% | Maintains | 5 months ago |
Privia Health Group IncPRVA | 5 | Buy | $31.00 | +35.08% | Maintains | 6 months ago |
Optimizerx CorpOPRX | 11 | Buy | $24.00 | +360.65% | Maintains | 6 months ago |
Waystar Holding CorpWAY | 1 | Buy | $48.00 | +167.71% | Initiates Coverage On | 8 months ago |
Axogen IncAXGN | 1 | Buy | $26.00 | N/A | Maintains | a year ago |
American Tower CorpAMT | 1 | Buy | $248.00 | N/A | Maintains | a year ago |
Agilon Health IncAGL | 1 | Buy | $450.00 | N/A | Initiates Coverage On | 2 years ago |
Nemaura Medical IncNMRD | 4 | Strong Buy | $4.00 | N/A | Maintains | 3 years ago |
Nanoviricides IncNNVC | 3 | Strong Buy | $5.25 | N/A | Assumes | 3 years ago |
Scienture Holdings IncSCNX | 2 | Strong Buy | $18.75 | N/A | Maintains | 3 years ago |
Longeveron IncLGVN | 5 | Strong Buy | $125.00 | N/A | Reiterates | 3 years ago |
Electromed IncELMD | 3 | Strong Buy | $15.00 | N/A | Reiterates | 3 years ago |
Innoviva IncINVA | 4 | Strong Buy | $22.50 | N/A | Reiterates | 3 years ago |
Carecloud IncCCLD | 2 | Strong Buy | $8.50 | N/A | Reiterates | 3 years ago |
Hoth Therapeutics IncHOTH | 4 | Strong Buy | $14.00 | N/A | Reiterates | 3 years ago |
Hcw Biologics IncHCWB | 4 | Strong Buy | $360.00 | N/A | Reiterates | 3 years ago |
Bone Biologics CorpBBLG | 3 | Strong Buy | $3,240.00 | N/A | Reiterates | 3 years ago |
Pasithea Therapeutics CorpKTTA | 2 | Strong Buy | $40.00 | N/A | Maintains | 3 years ago |
Acer Therapeutics IncACER | 2 | Strong Buy | $7.00 | N/A | Reiterates | 3 years ago |
Volitionrx LtdVNRX | 2 | Strong Buy | $120.00 | N/A | Reiterates | 3 years ago |
Grace Therapeutics IncGRCE | 2 | Strong Buy | $15.00 | N/A | Reiterates | 3 years ago |
Biovie IncBIVI | 2 | Strong Buy | $800.00 | N/A | Maintains | 4 years ago |
Healthcare Triangle IncHCTI | 2 | Strong Buy | $298,800.00 | N/A | Maintains | 4 years ago |
Ispecimen IncISPC | 2 | Strong Buy | $3,400.00 | N/A | Maintains | 4 years ago |
Invacare CorpIVCRQ | 1 | Strong Buy | $2.75 | N/A | Initiates Coverage On | 4 years ago |
Tc Biopharm PLCTCBP | 1 | Strong Buy | $8,000,000.00 | N/A | Initiates Coverage On | 4 years ago |
G Medical Innovations Holdings LtdGMVDF | 1 | Strong Buy | $210.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.